These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 23894025

  • 21. Third universal definition of myocardial infarction: update, caveats, differential diagnoses.
    Tehrani DM, Seto AH.
    Cleve Clin J Med; 2013 Dec; 80(12):777-86. PubMed ID: 24307162
    [Abstract] [Full Text] [Related]

  • 22. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Chaitman BR, Alexander KP, Cyr DD, Berger JS, Reynolds HR, Bangalore S, Boden WE, Lopes RD, Demkow M, Piero Perna G, Riezebos RK, McFalls EO, Banerjee S, Bagai A, Gosselin G, O'Brien SM, Rockhold FW, Waters DD, Thygesen KA, Stone GW, White HD, Maron DJ, Hochman JS, ISCHEMIA Research Group.
    Circulation; 2021 Feb 23; 143(8):790-804. PubMed ID: 33267610
    [Abstract] [Full Text] [Related]

  • 23. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE, Beijk MA, Damman P, Kuijt WJ, Woudstra P, Grundeken MJ, Kloek JJ, Tijssen JG, de Mol BA, de Winter RJ.
    J Cardiovasc Med (Hagerstown); 2013 Jun 23; 14(6):438-45. PubMed ID: 22828774
    [Abstract] [Full Text] [Related]

  • 24. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
    Hueb W, Gersh BJ, Rezende PC, Garzillo CL, Lima EG, Vieira RD, Garcia RM, Favarato D, Segre CA, Pereira AC, Soares PR, Ribeiro E, Lemos P, Perin MA, Strunz CC, Dallan LA, Jatene FB, Stolf NA, Hueb AC, Dias R, Gaiotto FA, da Costa LM, Oikawa FT, de Melo RM, Serrano CV, de Ávila LF, Villa AV, Filho JR, Nomura C, Ramires JA, Kalil Filho R, MASS-V Study Group.
    BMC Cardiovasc Disord; 2012 Aug 16; 12():65. PubMed ID: 22898311
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Is periprocedural CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins?
    Gollop ND, Dhullipala A, Nagrath N, Myint PK.
    Interact Cardiovasc Thorac Surg; 2013 Nov 16; 17(5):867-71. PubMed ID: 23842761
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Yang X, Tamez H, Lai C, Ho K, Cutlip D.
    Catheter Cardiovasc Interv; 2017 Apr 16; 89(5):849-856. PubMed ID: 27535209
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.
    Oikawa FTC, Hueb W, Nomura CH, Hueb AC, Villa AV, da Costa LMA, de Melo RMV, Rezende PC, Segre CAW, Garzillo CL, Lima EG, Ramires JAF, Filho RK.
    J Cardiothorac Surg; 2017 Dec 29; 12(1):122. PubMed ID: 29284532
    [Abstract] [Full Text] [Related]

  • 33. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS.
    Arterioscler Thromb Vasc Biol; 2013 Sep 29; 33(9):2252-60. PubMed ID: 23868944
    [Abstract] [Full Text] [Related]

  • 34. New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?
    Locca D, Bucciarelli-Ducci C, Ferrante G, La Manna A, Keenan NG, Grasso A, Barlis P, Del Furia F, Prasad SK, Kaski JC, Pennell DJ, Di Mario C.
    JACC Cardiovasc Interv; 2010 Sep 29; 3(9):950-8. PubMed ID: 20850095
    [Abstract] [Full Text] [Related]

  • 35. The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention.
    Milani RV, Fitzgerald R, Milani JN, Lavie CJ.
    Catheter Cardiovasc Interv; 2009 Nov 15; 74(6):819-22. PubMed ID: 19670308
    [Abstract] [Full Text] [Related]

  • 36. Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years.
    Costa FM, Ferreira J, Aguiar C, Dores H, Figueira J, Mendes M.
    Eur Heart J; 2012 Oct 15; 33(20):2544-50. PubMed ID: 22991454
    [Abstract] [Full Text] [Related]

  • 37. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India.
    J Assoc Physicians India; 2006 Jun 15; 54():469-80. PubMed ID: 16909697
    [Abstract] [Full Text] [Related]

  • 38. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Bulluck H, Paradies V, Barbato E, Baumbach A, Bøtker HE, Capodanno D, De Caterina R, Cavallini C, Davidson SM, Feldman DN, Ferdinandy P, Gili S, Gyöngyösi M, Kunadian V, Ooi SY, Madonna R, Marber M, Mehran R, Ndrepepa G, Perrino C, Schüpke S, Silvain J, Sluijter JPG, Tarantini G, Toth GG, Van Laake LW, von Birgelen C, Zeitouni M, Jaffe AS, Thygesen K, Hausenloy DJ.
    Eur Heart J; 2021 Jul 15; 42(27):2630-2642. PubMed ID: 34059914
    [Abstract] [Full Text] [Related]

  • 39. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.
    Wang HY, Xu B, Dou K, Guan C, Song L, Huang Y, Zhang R, Xie L, Zhang M, Yan H, Yang W, Wu Y, Yang Y, Qiao S, Gao R, Stone GW.
    JACC Cardiovasc Interv; 2021 Aug 09; 14(15):1623-1634. PubMed ID: 34353593
    [Abstract] [Full Text] [Related]

  • 40. [Prognostic significance of the elevation of the indices of myocardial damage after percutaneous coronary revascularization interventions].
    Cavallini C, Savonitto S.
    Ital Heart J Suppl; 2002 Mar 09; 3(3):286-96. PubMed ID: 12040844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.